From January 17, 2022 to March 31, 2022, the company has repurchased 246,000 shares, representing 2.46% for KRW 2,962.2 million. With this, the company has completed the repurchase of 246,000 shares, representing 2.46% for KRW 2,962.2 million under the buyback announced on January 17, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13,490 KRW | +7.06% | +3.13% | -8.11% |
14/02 | HansBiomed Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023 | CI |
2023 | HansBiomed Corporation(KOSDAQ:A042520) added to S&P Global BMI Index | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.11% | 13Cr | |
+10.86% | 13TCr | |
-5.84% | 1.13TCr | |
+4.17% | 912.22Cr | |
+40.13% | 560.73Cr | |
-21.47% | 474.63Cr | |
+8.77% | 345.34Cr | |
-6.03% | 288.74Cr | |
-12.05% | 207.12Cr | |
-7.83% | 205.48Cr |
- Stock Market
- Equities
- A042520 Stock
- News HansBiomed Corporation
- Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on January 17, 2022.